000			01448 a2200361 4500
005			20250516073402.0
264		0	_c20120405
008			201204s 0 0 eng d
022			_a1530-6550
024	7		_a10.3909/ricm0619 _2doi
040			_aNLM _beng _cNLM
100	1		_aMcCullough, Peter A
245	0	0	_aTreatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. _h[electronic resource]
260			_bReviews in cardiovascular medicine _c2011
300			_a173-85 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aCardiovascular Diseases _xprevention & control
650	0	4	_aCholesterol, HDL _xdrug effects
650	0	4	_aCholesterol, LDL _xdrug effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFibric Acids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aHypertriglyceridemia _xdrug therapy
650	0	4	_aParticle Size
650	0	4	_aRandomized Controlled Trials as Topic
700	1		_aAhmed, Amina B
700	1		_aZughaib, Marc T
700	1		_aGlanz, Eric D
700	1		_aDi Loreto, Michael J
773	0		_tReviews in cardiovascular medicine _gvol. 12 _gno. 4 _gp. 173-85
856	4	0	_uhttps://doi.org/10.3909/ricm0619 _zAvailable from publisher's website
999			_c21465175 _d21465175